Active Pharmaceutical Ingredients (APIs)
| Sr. no. | Therapeutic Category | Product | Pharmacopoeia | Documentation | Status |
| NSAID & Pain management |
Meloxicam | IP/ BP/ USP/ EP | DMF available | Commercial | |
| Lornoxicam | INH | EDMF, CHINESE DMF, RUSSIAN DMF, ODMF | Commercial | ||
| Tenoxicam | BP/ USP | Tech pack | Commercial | ||
| Piroxicam | BP/ USP | Tech pack | Commercial | ||
| Piroxicam-β-Cyclodextrin complex | INH | Tech pack | Commercial | ||
| Pregabalin | IP/ INH/ BP/ USP | Tech pack | Commercial | ||
| Etoricoxib | INH/ IP | Tech pack | Commercial | ||
| Respiratory | Bromhexine HCl | IP/ BP/ EP | DMF available | Commercial | |
| Salmeterol Xinafoate | EP | Tech pack | Commercial | ||
| Ambroxol HCl | BP/ USP | – | Under Development | ||
| Anti-Allergic | Fexofenadine | USP | Tech pack | Commercial | |
| Betahistine | BP/ EP/ USP | – | Under Development | ||
| Anti-Diabetic | Canagliflozin | INH | Tech pack | Commercial | |
| Linagliptin | INH | DMF available | Commercial | ||
| Dapagliflozin | INH | – | Under Development | ||
| Empagliflozin | INH | – | Under Development | ||
| Sitagliptin | INH/ USP | – | Under Development | ||
| Ophthalmic | Olopatadine HCl | IP/ USP | – | Under Development | |
| Excipient | Ethyl Oleate – IP/BP/USP | IP/ BP/ USP | Tech pack | Commercial | |
| Chlorobutanol Hemihydrate | EP/ BP/ USP | – | Under Development | ||
| Nutrition | |||||
| Iron Sucrose | INH | – | Under Development | ||
| Anti-Infective | Nitroxinil – BP | BP | – | Under Development | |
| Nitazoxanide INH/USP | INH/ USP | – | Under Development | ||
| Oxyclozanide – BP | BP | – | Under Development |
Note: All transactions are carried out in conformity with patent laws applicable in the buyer’s country. Responsibility with respect to third-party patent rights in a specific country lies exclusively with the buyer.